PL365279A1 - Aminowe pochodne biotyny i ich koniugaty z makrocyklicznymi cząstkami chelatującymi - Google Patents

Aminowe pochodne biotyny i ich koniugaty z makrocyklicznymi cząstkami chelatującymi

Info

Publication number
PL365279A1
PL365279A1 PL02365279A PL36527902A PL365279A1 PL 365279 A1 PL365279 A1 PL 365279A1 PL 02365279 A PL02365279 A PL 02365279A PL 36527902 A PL36527902 A PL 36527902A PL 365279 A1 PL365279 A1 PL 365279A1
Authority
PL
Poland
Prior art keywords
conjugates
derivates
biotin
chelating agents
preparation
Prior art date
Application number
PL02365279A
Other languages
English (en)
Other versions
PL202898B1 (pl
Inventor
Giovanni Paganelli
Marco Chinol
Mauro Ginanneschi
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of PL365279A1 publication Critical patent/PL365279A1/pl
Publication of PL202898B1 publication Critical patent/PL202898B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
PL365279A 2001-02-16 2002-02-15 Związek, związek kompleksowy, kompozycja farmaceutyczna lub diagnostyczna i ich zastosowanie oraz zestaw do radioterapii lub diagnozowania nowotworów PL202898B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000079A ITRM20010079A1 (it) 2001-02-16 2001-02-16 Amminoderivati della biotina e loro coniugati con chelanti macrociclici.
PCT/IT2002/000091 WO2002066075A2 (en) 2001-02-16 2002-02-15 Biotin-derivatives and their conjugates with chelating agents

Publications (2)

Publication Number Publication Date
PL365279A1 true PL365279A1 (pl) 2004-12-27
PL202898B1 PL202898B1 (pl) 2009-08-31

Family

ID=11455227

Family Applications (1)

Application Number Title Priority Date Filing Date
PL365279A PL202898B1 (pl) 2001-02-16 2002-02-15 Związek, związek kompleksowy, kompozycja farmaceutyczna lub diagnostyczna i ich zastosowanie oraz zestaw do radioterapii lub diagnozowania nowotworów

Country Status (19)

Country Link
US (2) US7390828B2 (pl)
EP (1) EP1359943B1 (pl)
JP (1) JP4469133B2 (pl)
KR (1) KR100860062B1 (pl)
CN (1) CN100457192C (pl)
AT (1) ATE306283T1 (pl)
AU (1) AU2002237517B2 (pl)
BR (1) BR0207327A (pl)
CZ (1) CZ305442B6 (pl)
DE (1) DE60206599T2 (pl)
DK (1) DK1359943T3 (pl)
ES (1) ES2248522T3 (pl)
HK (1) HK1068251A1 (pl)
HU (1) HU229160B1 (pl)
IT (1) ITRM20010079A1 (pl)
MX (1) MXPA03007317A (pl)
PL (1) PL202898B1 (pl)
SK (1) SK286112B6 (pl)
WO (1) WO2002066075A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030196A1 (it) * 2003-04-24 2004-10-25 Sigma Tau Ind Farmaceuti Uso di reagenti per la preparazione di un medicamento
ITRM20040105A1 (it) 2004-02-27 2004-05-27 Tecnogen Scpa Anticorpo monoclonale antitenascina umana.
ITRM20050345A1 (it) * 2005-06-30 2007-01-01 Sigma Tau Ind Farmaceuti Sintesi di deossi-biotinil esametilen diammina-dota.
TWI381852B (zh) * 2005-09-27 2013-01-11 Sigma Tau Ind Farmaceuti 生物素二胺基衍生物類及其與大環螯合劑之共軛物
ES2367675T3 (es) 2007-04-04 2011-11-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Anticuerpo anti-epcam y usos del mismo.
GB0922369D0 (en) 2009-12-22 2010-02-03 Hammersmith Imanet Ltd Labelled biotin conjugates
EP2630132A1 (en) * 2010-10-22 2013-08-28 Université de Strasbourg Pochoxime conjugates useful for the treatment of hsp90 related pathologies
CA2842276C (en) 2011-08-02 2020-11-24 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Pharmaceutical composition of oxidised avidin suitable for inhalation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283342A (en) * 1992-06-09 1994-02-01 Neorx Corporation Biotinylated small molecules
US6075010A (en) * 1992-06-09 2000-06-13 Neorx Corporation Small molecular weight ligand-hexose containing clearing agents
US6416738B1 (en) * 1973-12-07 2002-07-09 Neorx Corporation Pretargeting methods and compounds
DE3713842A1 (de) * 1987-04-22 1988-11-17 Schering Ag Substituierte cyclische komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
IT1245748B (it) 1990-12-21 1994-10-14 Mini Ricerca Scient Tecnolog Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego
US5616690A (en) * 1992-06-09 1997-04-01 Neorx Corporation Hexose derivatized human serum albumin clearing agents
US5624896A (en) * 1992-06-09 1997-04-29 Neorx Corporation Clearing agents useful in pretargeting methods
US5541287A (en) * 1992-06-09 1996-07-30 Neorx Corporation Pretargeting methods and compounds
EP1138334A3 (en) * 1992-06-09 2002-04-03 Neorx Corporation Pretargeting methods and compounds
US6217869B1 (en) * 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
US5914312A (en) * 1992-06-09 1999-06-22 Neorx Corporation Pretargeting methods and compounds
US6358490B2 (en) * 1992-06-09 2002-03-19 Neorx Corporation Three-step pretargeting methods and compounds
US5976535A (en) * 1992-06-09 1999-11-02 Neorx Corporation Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
US5911969A (en) * 1992-06-09 1999-06-15 Neorx Corporation Pretargeting protocols for enhanced localization of active agents to target sites
US5578287A (en) * 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
US6120768A (en) * 1993-05-17 2000-09-19 Immunomedics, Inc. Dota-biotin derivatives
JPH0730748U (ja) * 1993-11-29 1995-06-13 花王株式会社 歯ブラシ
US5955605A (en) * 1995-02-21 1999-09-21 Neorx Corporation Biotinidase resistant biotin-DOTA conjugates
JPH11513374A (ja) * 1995-09-18 1999-11-16 マリンクロッド・メディカル・インコーポレイテッド （放射性）標識化ビオチン誘導体類
JP3427871B2 (ja) * 1996-06-24 2003-07-22 戸田工業株式会社 コバルト被着型針状磁性酸化鉄粒子粉末
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms

Also Published As

Publication number Publication date
DK1359943T3 (da) 2006-01-02
BR0207327A (pt) 2004-02-10
US20040067199A1 (en) 2004-04-08
EP1359943B1 (en) 2005-10-12
US8044081B2 (en) 2011-10-25
HUP0303151A3 (en) 2010-01-28
EP1359943A2 (en) 2003-11-12
ATE306283T1 (de) 2005-10-15
KR20030072627A (ko) 2003-09-15
HUP0303151A2 (hu) 2003-12-29
DE60206599D1 (de) 2005-11-17
KR100860062B1 (ko) 2008-09-24
AU2002237517B2 (en) 2006-11-30
MXPA03007317A (es) 2004-06-30
SK286112B6 (sk) 2008-03-05
SK11152003A3 (sk) 2004-02-03
JP2004524305A (ja) 2004-08-12
CN1531445A (zh) 2004-09-22
WO2002066075A3 (en) 2003-01-30
CZ305442B6 (cs) 2015-09-23
PL202898B1 (pl) 2009-08-31
DE60206599T2 (de) 2006-06-22
JP4469133B2 (ja) 2010-05-26
US20080085239A1 (en) 2008-04-10
ITRM20010079A0 (it) 2001-02-16
US7390828B2 (en) 2008-06-24
CZ20031989A3 (cs) 2004-02-18
HK1068251A1 (en) 2005-04-29
HU229160B1 (hu) 2013-09-30
ES2248522T3 (es) 2006-03-16
WO2002066075A2 (en) 2002-08-29
CN100457192C (zh) 2009-02-04
ITRM20010079A1 (it) 2002-08-16

Similar Documents

Publication Publication Date Title
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
AU2003205077A1 (en) Imaging agents and methods of imaging naaladase of psma
HK1068251A1 (en) Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
MXPA02010801A (es) Agentes diagnosticos, de representacion y terapeuticos cationicos asociados con sitios vasculares activados.
YU50800A (sh) Derivati 2-(purin-9-il)-tetrahidrofuran-3,4-diola
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
DE60112974D1 (en) Carbolinderivate
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
TR200100805T2 (tr) Tetrahidropiridoeterler
UA85559C2 (en) Aminobenzophenone compounds
DE60216233D1 (en) Carbolinderivate
DE60033649D1 (de) Verbindungen und therapeutische methoden
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
PT1381611E (pt) Analogos de ftalocianina substituidas com metal sem centro de simetria sua preparacao e uso em terapia fotodinamica e em diagnostico in vivo
HK1040983B (zh) 用於治療疾病的醌類
ATE386742T1 (de) Imidazonaphthyridine
TW200744647A (en) Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
EP1420814A4 (en) COMPOSITIONS AND TECHNIQUES FOR THERAPY AND DIAGNOSIS OF BREAST CANCER
IL159479A (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
AU8445791A (en) Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
ZA981558B (en) Inclusion complexes in aqueous solution
EP1578353A4 (en) METHODS OF USE AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF INFECTION DISEASES